Drug allergy in children: focus on beta-lactams and NSAIDs - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Acta Biomedica- Ateneo Parmense Année : 2020

Drug allergy in children: focus on beta-lactams and NSAIDs

Résumé

Drug hypersensitivity reactions (DHRs) are adverse reactions to a drug. In children, most common drugs inducing such reactions include beta-lactams (BLs) and non-steroidal anti-inflammatory drugs (NSAIDs). The aim of the present work was to provide current knowledge on the management of DHRs in the pediatric population, focusing on BLs and NSAIDs hypersensitivity. The clinical feature of DHRs include immediate and non-immediate (delayed and accelerated) reactions, that may be severe or non-severe. A systematic approach to the patient based on the reported clinical history is essential to organize a safe and adapted allergy work-up. Skin tests are the first step to assess a possible DHRs, especially in immediate reactions to BLs. Drugs concentrations for these tests are standardized and validated. The drug provocation test remains the gold standard to reach a firm diagnosis. In selected cases, a therapeutic desensitization protocol may be proposed in children with a confirmed diagnosis of drug hypersensitivity. Clinicians should be aware of the diagnostic and therapeutic options, to provide the best management in children having experienced a history of DHR. (www.actabiomedica.it)
Fichier principal
Vignette du fichier
ACTA-91-08.pdf (828.43 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03704942 , version 1 (26-06-2022)

Identifiants

Citer

Claudio Cravidi, Silvia Caimmi, Maria de Filippo, Alberto Martelli, Carlo Caffarelli, et al.. Drug allergy in children: focus on beta-lactams and NSAIDs. Acta Biomedica- Ateneo Parmense, 2020, Advances in Allergy and Clinical Immunology in Children, 91 (11-S), pp.e2020008. ⟨10.23750/abm.v91i11-S.10312⟩. ⟨hal-03704942⟩
12 Consultations
15 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More